Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) EPS (Basic) (2022 - 2025)

Historic EPS (Basic) for Praxis Precision Medicines (PRAX) over the last 4 years, with Q3 2025 value amounting to -$3.36.

  • Praxis Precision Medicines' EPS (Basic) fell 2218.18% to -$3.36 in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.96, marking a year-over-year decrease of 3950.48%. This contributed to the annual value of -$11.18 for FY2024, which is 4019.18% up from last year.
  • As of Q3 2025, Praxis Precision Medicines' EPS (Basic) stood at -$3.36, which was down 2218.18% from -$3.31 recorded in Q2 2025.
  • In the past 5 years, Praxis Precision Medicines' EPS (Basic) registered a high of -$0.96 during Q3 2022, and its lowest value of -$65.86 during Q4 2022.
  • Over the past 4 years, Praxis Precision Medicines' median EPS (Basic) value was -$2.84 (recorded in 2024), while the average stood at -$7.54.
  • Data for Praxis Precision Medicines' EPS (Basic) shows a peak YoY increase of 9702.4% (in 2023) and a maximum YoY decrease of 60066.23% (in 2023) over the last 5 years.
  • Quarter analysis of 4 years shows Praxis Precision Medicines' EPS (Basic) stood at -$65.86 in 2022, then surged by 97.02% to -$1.96 in 2023, then crashed by 82.22% to -$3.57 in 2024, then rose by 5.92% to -$3.36 in 2025.
  • Its last three reported values are -$3.36 in Q3 2025, -$3.31 for Q2 2025, and -$3.29 during Q1 2025.